Chronic lymphocytic leukaemia at a country hospital in southern Sweden

被引:2
作者
Hjalmar, V
Carlsson, M
Kimby, E
机构
[1] Department of Medicine, County Hospital Ryhov, Jönköping
[2] Department of Medicine, Karolinska Institute
[3] Department of Hematology, Huddinge Hospital
[4] Division of Hematology, Karolinska Institute, Danderyd Hospital
来源
MEDICAL ONCOLOGY | 1996年 / 13卷 / 02期
关键词
chronic lymphocytic leukaemia; natural course; Sweden;
D O I
10.1007/BF02993859
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We have studied retrospectively patients with chronic lymphocytic leukaemia (CLL), at Ryhov, Jonkoping, Sweden during a 10-year-period. This unselected cohort (n = 59) from a well-defined geographical area is suitable for describing the natural course of the disease. The CLL was diagnosed incidentally in the majority of cases. Median-age at diagnosis was 71 years and the male:female ratio was 1.3:1. The diagnosis was based on morphology in 66% and in 33% immunophenotyping specified the diagnosis of B- or T-CLL. At diagnosis 66% were in Rai-stage O/I or Binet-stage A. There were 36% untreated patients and their median-survival was 108 months compared with 84 months for the whole cohort and 72 months for the treated patients. Malignancies were seen in 31% and infections in 83%. Intercurrent diseases played an important role in the survival. During the observation time, only 54% of the deceased patients had died due to the CLL.
引用
收藏
页码:95 / 101
页数:7
相关论文
共 19 条
[1]  
BINET JL, 1981, CANCER-AM CANCER SOC, V48, P198, DOI 10.1002/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO
[2]  
2-V
[3]  
CHAPEL HM, 1991, J CLIN IMMUNOL, V12, P17
[4]  
DICATO M, 1991, CANCER, V68, P1437, DOI 10.1002/1097-0142(19910915)68:6+<1437::AID-CNCR2820681406>3.0.CO
[5]  
2-H
[6]  
ERLANSON M, 1994, EUR J HAEMATOL, V52, P108
[7]  
*FRENCH COOP GROUP, 1991, BLOOD, V78, P1901
[8]   THE TROMSO STUDY - FACTORS AFFECTING PATIENT-INITIATED AND PROVIDER-INITIATED USE OF HEALTH-CARE SERVICES [J].
FYLKESNES, K ;
JOHNSEN, R ;
FORDE, OH .
SOCIOLOGY OF HEALTH & ILLNESS, 1992, 14 (02) :275-292
[9]   AUTOIMMUNITY IN CHRONIC LYMPHOCYTIC-LEUKEMIA [J].
HAMBLIN, TJ ;
OSCIER, DG ;
YOUNG, BJ .
JOURNAL OF CLINICAL PATHOLOGY, 1986, 39 (07) :713-716
[10]   TREATMENT OF CHRONIC LYMPHOCYTIC-LEUKEMIA AND WELL-DIFFERENTIATED LYMPHOCYTIC LYMPHOMA WITH CONTINUOUS LOW-DOSE OR INTERMITTENT HIGH-DOSE PREDNIMUSTINE VERSUS CHLORAMBUCIL PREDNISOLONE [J].
IDESTROM, K ;
KIMBY, E ;
BJORKHOLM, M ;
MELLSTEDT, H ;
ENGSTEDT, L ;
GAHRTON, G ;
JOHANSSON, B ;
KILLANDER, D ;
ROBERTS, KH ;
STALFELT, AM ;
UDEN, AM ;
WADMAN, B ;
WAHLBY, S .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1982, 18 (11) :1117-1123